Literature DB >> 6116605

A controlled study of the antihypertensive effect of carteolol, a new beta-adrenergic receptor blocking drug, in combination with hydrochlorothiazide and amiloride.

A Tarkiainen, K Saraste, T Seppälä, A Gordin, J Auvinen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6116605     DOI： 10.1007/bf00562799

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  10 in total

1.  Return of elevated blood pressure after withdrawal of antihypertensive drugs.

Authors: 
Journal:  Circulation       Date:  1975-06       Impact factor: 29.690

2.  Comparison of newly synthesized beta-adrenergic blockers, OPC 1085 and SQ 11725, with pindolol and propranolol in the blood-perfused canine SA node and papillary muscle preparations.

Authors:  K Hashimoto; T Kimura; Y Yabuuchi
Journal:  Jpn J Pharmacol       Date:  1976-08

3.  [Metabolic fate of carteolol hydrochloride (OPC-1085), a new beta-adrenergic agent. (3) Autoradiographic total body distribution studies in mice].

Authors:  H Kohri; S Morita; K Nakagawa; H Nishino
Journal:  Nihon Yakurigaku Zasshi       Date:  1976-04

4.  Metabolic fate of carteolol hydrochloride, (OPC-1085) VIII, a new beta-adrenergic blocking agent. Pharmacokinetic studies of carteolol in man.

Authors:  S Morita; M Iinuma; M Kido; S Sakuragi; H Kohri; H Nishino
Journal:  Arzneimittelforschung       Date:  1977

5.  Pharmacokinetics of pindolol in man.

Authors:  R Gugler; W Herold; H J Dengler
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

Review 6.  Perspectives in adrenergic beta-receptor blockade.

Authors:  J D Fitzgerald
Journal:  Clin Pharmacol Ther       Date:  1969 May-Jun       Impact factor: 6.875

7.  [Effects of 5-(3-tert-butylamino-2-hydroxy) propoxy-3,4-dihydrocarbostyril hydrochloride(OPC-1085) on coronary circulation and myocardial metabolism].

Authors:  F Takenaka; S Shintani; T Ishihara; M Higuchi; I Hiraki
Journal:  Nihon Yakurigaku Zasshi       Date:  1975-03

8.  The effect on blood pressure of beta-adrenoceptor blocking drugs administered once daily and their duration of action when therapy is ceased.

Authors:  M Wilson; G Morgan; T Morgan
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

9.  Derivatives of 3,4-dihydrocarbostyril as beta-adrenergic blocking agents.

Authors:  K Nakagawa; N Murakami; S Yoshizaki; M Tominaga; H Mori
Journal:  J Med Chem       Date:  1974-05       Impact factor: 7.446

10.  Cardiovascular studies of 5-(3-tert-butylamino-2-hydroxy) propoxy-3,4-dihydrocarbostyril hydrochloride (OPC-1085), a new potent beta-adrenergic blocking agent.

Authors:  Y Yabuochi; D Kinoshita
Journal:  Jpn J Pharmacol       Date:  1974-12
  10 in total
  2 in total

1.  Pharmacokinetics and absolute bioavailability of carteolol, a new beta-adrenergic receptor blocking agent.

Authors:  T Ishizaki; A Ohnishi; T Sasaki; K Kushida; Y Horai; K Chiba; T Suganuma
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

2.  Pharmacokinetics of carteolol in patients with impaired renal function.

Authors:  M Amemiya; K Tabei; H Furuya; Y Sakairi; Y Asano
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.